Key result
FDA-cleared blood pressure devices may lack sufficient reliability, prompting a call to action for improved validation and clinical scrutiny.
Key points are not available for this paper at this time.
Design
Editorial
An editorial calling to action regarding the trustworthiness of FDA-cleared blood pressure devices.
Department of Pediatrics, University of Tennessee Health Science Center (Retired), Memphis, Tennessee, USA Correspondence to Bruce S. Alpert, MD, 1350 Poplar Ridge Dr., Memphis, TN 38120, USA Tel: +1 901 229 3719; fax: +1 901 757 8181; e-mail: [email protected] Received March 13, 2017 Accepted June 21, 2017
No takes yet. Share an insight, caveat, or question.
Bruce S. Alpert (2017) studied this question. FDA-cleared blood pressure devices may lack sufficient reliability, prompting a call to action for improved validation and clinical scrutiny.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: